aluates Reports

$ 0.0

Automative

Global Psoriasis Treatment Drugs Market Research Report 2025

Published Date: January 2025

Report Code: QYRE-Auto-11B11663

Global Psoriasis Treatment Drugs Market Research Report 2022

BUY CHAPTERS

Global Psoriasis Treatment Drugs Market Research Report 2025

Code: QYRE-Auto-11B11663

Report

January 2025

Pages:83

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Amgen Inc

Allergan plc

Dermira

Eli Lilly

Novartis

Merck

Johnson & Johnson

Pfizer Inc

Astrazeneca plc

AbbVie

LEO Pharma

Biogen

Galectin Therapeutics

Cellceutix

Bayer

Psoriasis Treatment Drugs Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Psoriasis Treatment Drugs Market

The global market for Psoriasis Treatment Drugs was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Psoriasis Treatment Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Psoriasis Treatment Drugs.

The Psoriasis Treatment Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Psoriasis Treatment Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Psoriasis Treatment Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Psoriasis Treatment Drugs Market Report

Report Metric	Details
Report Name	Psoriasis Treatment Drugs Market
CAGR	5%
Segment by Type	TNF Inhibitors Interleukin Inhibitors Vitamin D Analogs Corticosteroids Others
Segment by Application	Oral Parenteral Topical
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Amgen, Allergan, Dermira, Eli Lilly, Novartis, Merck, Johnson & Johnson, Pfizer, AstraZeneca, AbbVie, LEO Pharma, Biogen, Galectin Therapeutics, Cellceutix, Bayer
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Psoriasis Treatment Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Psoriasis Treatment Drugs Market report?

Ans: The main players in the Psoriasis Treatment Drugs Market are Amgen, Allergan, Dermira, Eli Lilly, Novartis, Merck, Johnson & Johnson, Pfizer, AstraZeneca, AbbVie, LEO Pharma, Biogen, Galectin Therapeutics, Cellceutix, Bayer

What are the Application segmentation covered in the Psoriasis Treatment Drugs Market report?

Ans: The Applications covered in the Psoriasis Treatment Drugs Market report are Oral, Parenteral, Topical

What are the Type segmentation covered in the Psoriasis Treatment Drugs Market report?

Ans: The Types covered in the Psoriasis Treatment Drugs Market report are TNF Inhibitors, Interleukin Inhibitors, Vitamin D Analogs, Corticosteroids, Others

Recommended Reports

Dermatology Treatments

Chronic Disease Drugs

Pharmaceutical Drug Markets

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Psoriasis Treatment Drugs Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 TNF Inhibitors

1.2.3 Interleukin Inhibitors

1.2.4 Vitamin D Analogs

1.2.5 Corticosteroids

1.2.6 Others

1.3 Market by Application

1.3.1 Global Psoriasis Treatment Drugs Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Oral

1.3.3 Parenteral

1.3.4 Topical

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Psoriasis Treatment Drugs Market Perspective (2020-2031)

2.2 Global Psoriasis Treatment Drugs Growth Trends by Region

2.2.1 Global Psoriasis Treatment Drugs Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Psoriasis Treatment Drugs Historic Market Size by Region (2020-2025)

2.2.3 Psoriasis Treatment Drugs Forecasted Market Size by Region (2026-2031)

2.3 Psoriasis Treatment Drugs Market Dynamics

2.3.1 Psoriasis Treatment Drugs Industry Trends

2.3.2 Psoriasis Treatment Drugs Market Drivers

2.3.3 Psoriasis Treatment Drugs Market Challenges

2.3.4 Psoriasis Treatment Drugs Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Psoriasis Treatment Drugs Players by Revenue

3.1.1 Global Top Psoriasis Treatment Drugs Players by Revenue (2020-2025)

3.1.2 Global Psoriasis Treatment Drugs Revenue Market Share by Players (2020-2025)

3.2 Global Psoriasis Treatment Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Psoriasis Treatment Drugs Revenue

3.4 Global Psoriasis Treatment Drugs Market Concentration Ratio

3.4.1 Global Psoriasis Treatment Drugs Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Psoriasis Treatment Drugs Revenue in 2024

3.5 Global Key Players of Psoriasis Treatment Drugs Head office and Area Served

3.6 Global Key Players of Psoriasis Treatment Drugs, Product and Application

3.7 Global Key Players of Psoriasis Treatment Drugs, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Psoriasis Treatment Drugs Breakdown Data by Type

4.1 Global Psoriasis Treatment Drugs Historic Market Size by Type (2020-2025)

4.2 Global Psoriasis Treatment Drugs Forecasted Market Size by Type (2026-2031)

5 Psoriasis Treatment Drugs Breakdown Data by Application

5.1 Global Psoriasis Treatment Drugs Historic Market Size by Application (2020-2025)

5.2 Global Psoriasis Treatment Drugs Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Psoriasis Treatment Drugs Market Size (2020-2031)

6.2 North America Psoriasis Treatment Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Psoriasis Treatment Drugs Market Size by Country (2020-2025)

6.4 North America Psoriasis Treatment Drugs Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Psoriasis Treatment Drugs Market Size (2020-2031)

7.2 Europe Psoriasis Treatment Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Psoriasis Treatment Drugs Market Size by Country (2020-2025)

7.4 Europe Psoriasis Treatment Drugs Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Psoriasis Treatment Drugs Market Size (2020-2031)

8.2 Asia-Pacific Psoriasis Treatment Drugs Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Psoriasis Treatment Drugs Market Size by Region (2020-2025)

8.4 Asia-Pacific Psoriasis Treatment Drugs Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Psoriasis Treatment Drugs Market Size (2020-2031)

9.2 Latin America Psoriasis Treatment Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Psoriasis Treatment Drugs Market Size by Country (2020-2025)

9.4 Latin America Psoriasis Treatment Drugs Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Psoriasis Treatment Drugs Market Size (2020-2031)

10.2 Middle East & Africa Psoriasis Treatment Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Psoriasis Treatment Drugs Market Size by Country (2020-2025)

10.4 Middle East & Africa Psoriasis Treatment Drugs Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Amgen

11.1.1 Amgen Company Details

11.1.2 Amgen Business Overview

11.1.3 Amgen Psoriasis Treatment Drugs Introduction

11.1.4 Amgen Revenue in Psoriasis Treatment Drugs Business (2020-2025)

11.1.5 Amgen Recent Development

11.2 Allergan

11.2.1 Allergan Company Details

11.2.2 Allergan Business Overview

11.2.3 Allergan Psoriasis Treatment Drugs Introduction

11.2.4 Allergan Revenue in Psoriasis Treatment Drugs Business (2020-2025)

11.2.5 Allergan Recent Development

11.3 Dermira

11.3.1 Dermira Company Details

11.3.2 Dermira Business Overview

11.3.3 Dermira Psoriasis Treatment Drugs Introduction

11.3.4 Dermira Revenue in Psoriasis Treatment Drugs Business (2020-2025)

11.3.5 Dermira Recent Development

11.4 Eli Lilly

11.4.1 Eli Lilly Company Details

11.4.2 Eli Lilly Business Overview

11.4.3 Eli Lilly Psoriasis Treatment Drugs Introduction

11.4.4 Eli Lilly Revenue in Psoriasis Treatment Drugs Business (2020-2025)

11.4.5 Eli Lilly Recent Development

11.5 Novartis

11.5.1 Novartis Company Details

11.5.2 Novartis Business Overview

11.5.3 Novartis Psoriasis Treatment Drugs Introduction

11.5.4 Novartis Revenue in Psoriasis Treatment Drugs Business (2020-2025)

11.5.5 Novartis Recent Development

11.6 Merck

11.6.1 Merck Company Details

11.6.2 Merck Business Overview

11.6.3 Merck Psoriasis Treatment Drugs Introduction

11.6.4 Merck Revenue in Psoriasis Treatment Drugs Business (2020-2025)

11.6.5 Merck Recent Development

11.7 Johnson & Johnson

11.7.1 Johnson & Johnson Company Details

11.7.2 Johnson & Johnson Business Overview

11.7.3 Johnson & Johnson Psoriasis Treatment Drugs Introduction

11.7.4 Johnson & Johnson Revenue in Psoriasis Treatment Drugs Business (2020-2025)

11.7.5 Johnson & Johnson Recent Development

11.8 Pfizer

11.8.1 Pfizer Company Details

11.8.2 Pfizer Business Overview

11.8.3 Pfizer Psoriasis Treatment Drugs Introduction

11.8.4 Pfizer Revenue in Psoriasis Treatment Drugs Business (2020-2025)

11.8.5 Pfizer Recent Development

11.9 AstraZeneca

11.9.1 AstraZeneca Company Details

11.9.2 AstraZeneca Business Overview

11.9.3 AstraZeneca Psoriasis Treatment Drugs Introduction

11.9.4 AstraZeneca Revenue in Psoriasis Treatment Drugs Business (2020-2025)

11.9.5 AstraZeneca Recent Development

11.10 AbbVie

11.10.1 AbbVie Company Details

11.10.2 AbbVie Business Overview

11.10.3 AbbVie Psoriasis Treatment Drugs Introduction

11.10.4 AbbVie Revenue in Psoriasis Treatment Drugs Business (2020-2025)

11.10.5 AbbVie Recent Development

11.11 LEO Pharma

11.11.1 LEO Pharma Company Details

11.11.2 LEO Pharma Business Overview

11.11.3 LEO Pharma Psoriasis Treatment Drugs Introduction

11.11.4 LEO Pharma Revenue in Psoriasis Treatment Drugs Business (2020-2025)

11.11.5 LEO Pharma Recent Development

11.12 Biogen

11.12.1 Biogen Company Details

11.12.2 Biogen Business Overview

11.12.3 Biogen Psoriasis Treatment Drugs Introduction

11.12.4 Biogen Revenue in Psoriasis Treatment Drugs Business (2020-2025)

11.12.5 Biogen Recent Development

11.13 Galectin Therapeutics

11.13.1 Galectin Therapeutics Company Details

11.13.2 Galectin Therapeutics Business Overview

11.13.3 Galectin Therapeutics Psoriasis Treatment Drugs Introduction

11.13.4 Galectin Therapeutics Revenue in Psoriasis Treatment Drugs Business (2020-2025)

11.13.5 Galectin Therapeutics Recent Development

11.14 Cellceutix

11.14.1 Cellceutix Company Details

11.14.2 Cellceutix Business Overview

11.14.3 Cellceutix Psoriasis Treatment Drugs Introduction

11.14.4 Cellceutix Revenue in Psoriasis Treatment Drugs Business (2020-2025)

11.14.5 Cellceutix Recent Development

11.15 Bayer

11.15.1 Bayer Company Details

11.15.2 Bayer Business Overview

11.15.3 Bayer Psoriasis Treatment Drugs Introduction

11.15.4 Bayer Revenue in Psoriasis Treatment Drugs Business (2020-2025)

11.15.5 Bayer Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Amgen Inc

Allergan plc

Dermira

Eli Lilly

Novartis

Merck

Johnson & Johnson

Pfizer Inc

Astrazeneca plc

AbbVie

LEO Pharma

Biogen

Galectin Therapeutics

Cellceutix

Bayer

List of Tables

Table 1. Global Psoriasis Treatment Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of TNF Inhibitors

Table 3. Key Players of Interleukin Inhibitors

Table 4. Key Players of Vitamin D Analogs

Table 5. Key Players of Corticosteroids

Table 6. Key Players of Others

Table 7. Global Psoriasis Treatment Drugs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Psoriasis Treatment Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 9. Global Psoriasis Treatment Drugs Market Size by Region (2020-2025) & (US$ Million)

Table 10. Global Psoriasis Treatment Drugs Market Share by Region (2020-2025)

Table 11. Global Psoriasis Treatment Drugs Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 12. Global Psoriasis Treatment Drugs Market Share by Region (2026-2031)

Table 13. Psoriasis Treatment Drugs Market Trends

Table 14. Psoriasis Treatment Drugs Market Drivers

Table 15. Psoriasis Treatment Drugs Market Challenges

Table 16. Psoriasis Treatment Drugs Market Restraints

Table 17. Global Psoriasis Treatment Drugs Revenue by Players (2020-2025) & (US$ Million)

Table 18. Global Psoriasis Treatment Drugs Market Share by Players (2020-2025)

Table 19. Global Top Psoriasis Treatment Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Psoriasis Treatment Drugs as of 2024)

Table 20. Ranking of Global Top Psoriasis Treatment Drugs Companies by Revenue (US$ Million) in 2024

Table 21. Global 5 Largest Players Market Share by Psoriasis Treatment Drugs Revenue (CR5 and HHI) & (2020-2025)

Table 22. Global Key Players of Psoriasis Treatment Drugs, Headquarters and Area Served

Table 23. Global Key Players of Psoriasis Treatment Drugs, Product and Application

Table 24. Global Key Players of Psoriasis Treatment Drugs, Date of Enter into This Industry

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global Psoriasis Treatment Drugs Market Size by Type (2020-2025) & (US$ Million)

Table 27. Global Psoriasis Treatment Drugs Revenue Market Share by Type (2020-2025)

Table 28. Global Psoriasis Treatment Drugs Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 29. Global Psoriasis Treatment Drugs Revenue Market Share by Type (2026-2031)

Table 30. Global Psoriasis Treatment Drugs Market Size by Application (2020-2025) & (US$ Million)

Table 31. Global Psoriasis Treatment Drugs Revenue Market Share by Application (2020-2025)

Table 32. Global Psoriasis Treatment Drugs Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 33. Global Psoriasis Treatment Drugs Revenue Market Share by Application (2026-2031)

Table 34. North America Psoriasis Treatment Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. North America Psoriasis Treatment Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 36. North America Psoriasis Treatment Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 37. Europe Psoriasis Treatment Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 38. Europe Psoriasis Treatment Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 39. Europe Psoriasis Treatment Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 40. Asia-Pacific Psoriasis Treatment Drugs Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 41. Asia-Pacific Psoriasis Treatment Drugs Market Size by Region (2020-2025) & (US$ Million)

Table 42. Asia-Pacific Psoriasis Treatment Drugs Market Size by Region (2026-2031) & (US$ Million)

Table 43. Latin America Psoriasis Treatment Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Latin America Psoriasis Treatment Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 45. Latin America Psoriasis Treatment Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 46. Middle East & Africa Psoriasis Treatment Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 47. Middle East & Africa Psoriasis Treatment Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 48. Middle East & Africa Psoriasis Treatment Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 49. Amgen Company Details

Table 50. Amgen Business Overview

Table 51. Amgen Psoriasis Treatment Drugs Product

Table 52. Amgen Revenue in Psoriasis Treatment Drugs Business (2020-2025) & (US$ Million)

Table 53. Amgen Recent Development

Table 54. Allergan Company Details

Table 55. Allergan Business Overview

Table 56. Allergan Psoriasis Treatment Drugs Product

Table 57. Allergan Revenue in Psoriasis Treatment Drugs Business (2020-2025) & (US$ Million)

Table 58. Allergan Recent Development

Table 59. Dermira Company Details

Table 60. Dermira Business Overview

Table 61. Dermira Psoriasis Treatment Drugs Product

Table 62. Dermira Revenue in Psoriasis Treatment Drugs Business (2020-2025) & (US$ Million)

Table 63. Dermira Recent Development

Table 64. Eli Lilly Company Details

Table 65. Eli Lilly Business Overview

Table 66. Eli Lilly Psoriasis Treatment Drugs Product

Table 67. Eli Lilly Revenue in Psoriasis Treatment Drugs Business (2020-2025) & (US$ Million)

Table 68. Eli Lilly Recent Development

Table 69. Novartis Company Details

Table 70. Novartis Business Overview

Table 71. Novartis Psoriasis Treatment Drugs Product

Table 72. Novartis Revenue in Psoriasis Treatment Drugs Business (2020-2025) & (US$ Million)

Table 73. Novartis Recent Development

Table 74. Merck Company Details

Table 75. Merck Business Overview

Table 76. Merck Psoriasis Treatment Drugs Product

Table 77. Merck Revenue in Psoriasis Treatment Drugs Business (2020-2025) & (US$ Million)

Table 78. Merck Recent Development

Table 79. Johnson & Johnson Company Details

Table 80. Johnson & Johnson Business Overview

Table 81. Johnson & Johnson Psoriasis Treatment Drugs Product

Table 82. Johnson & Johnson Revenue in Psoriasis Treatment Drugs Business (2020-2025) & (US$ Million)

Table 83. Johnson & Johnson Recent Development

Table 84. Pfizer Company Details

Table 85. Pfizer Business Overview

Table 86. Pfizer Psoriasis Treatment Drugs Product

Table 87. Pfizer Revenue in Psoriasis Treatment Drugs Business (2020-2025) & (US$ Million)

Table 88. Pfizer Recent Development

Table 89. AstraZeneca Company Details

Table 90. AstraZeneca Business Overview

Table 91. AstraZeneca Psoriasis Treatment Drugs Product

Table 92. AstraZeneca Revenue in Psoriasis Treatment Drugs Business (2020-2025) & (US$ Million)

Table 93. AstraZeneca Recent Development

Table 94. AbbVie Company Details

Table 95. AbbVie Business Overview

Table 96. AbbVie Psoriasis Treatment Drugs Product

Table 97. AbbVie Revenue in Psoriasis Treatment Drugs Business (2020-2025) & (US$ Million)

Table 98. AbbVie Recent Development

Table 99. LEO Pharma Company Details

Table 100. LEO Pharma Business Overview

Table 101. LEO Pharma Psoriasis Treatment Drugs Product

Table 102. LEO Pharma Revenue in Psoriasis Treatment Drugs Business (2020-2025) & (US$ Million)

Table 103. LEO Pharma Recent Development

Table 104. Biogen Company Details

Table 105. Biogen Business Overview

Table 106. Biogen Psoriasis Treatment Drugs Product

Table 107. Biogen Revenue in Psoriasis Treatment Drugs Business (2020-2025) & (US$ Million)

Table 108. Biogen Recent Development

Table 109. Galectin Therapeutics Company Details

Table 110. Galectin Therapeutics Business Overview

Table 111. Galectin Therapeutics Psoriasis Treatment Drugs Product

Table 112. Galectin Therapeutics Revenue in Psoriasis Treatment Drugs Business (2020-2025) & (US$ Million)

Table 113. Galectin Therapeutics Recent Development

Table 114. Cellceutix Company Details

Table 115. Cellceutix Business Overview

Table 116. Cellceutix Psoriasis Treatment Drugs Product

Table 117. Cellceutix Revenue in Psoriasis Treatment Drugs Business (2020-2025) & (US$ Million)

Table 118. Cellceutix Recent Development

Table 119. Bayer Company Details

Table 120. Bayer Business Overview

Table 121. Bayer Psoriasis Treatment Drugs Product

Table 122. Bayer Revenue in Psoriasis Treatment Drugs Business (2020-2025) & (US$ Million)

Table 123. Bayer Recent Development

Table 124. Research Programs/Design for This Report

Table 125. Key Data Information from Secondary Sources

Table 126. Key Data Information from Primary Sources

Table 127. Authors List of This Report

List of Figures

Figure 1. Psoriasis Treatment Drugs Picture

Figure 2. Global Psoriasis Treatment Drugs Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Psoriasis Treatment Drugs Market Share by Type: 2024 VS 2031

Figure 4. TNF Inhibitors Features

Figure 5. Interleukin Inhibitors Features

Figure 6. Vitamin D Analogs Features

Figure 7. Corticosteroids Features

Figure 8. Others Features

Figure 9. Global Psoriasis Treatment Drugs Market Size by Application (2020-2031) & (US$ Million)

Figure 10. Global Psoriasis Treatment Drugs Market Share by Application: 2024 VS 2031

Figure 11. Oral Case Studies

Figure 12. Parenteral Case Studies

Figure 13. Topical Case Studies

Figure 14. Psoriasis Treatment Drugs Report Years Considered

Figure 15. Global Psoriasis Treatment Drugs Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 16. Global Psoriasis Treatment Drugs Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 17. Global Psoriasis Treatment Drugs Market Share by Region: 2024 VS 2031

Figure 18. Global Psoriasis Treatment Drugs Market Share by Players in 2024

Figure 19. Global Top Psoriasis Treatment Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Psoriasis Treatment Drugs as of 2024)

Figure 20. The Top 10 and 5 Players Market Share by Psoriasis Treatment Drugs Revenue in 2024

Figure 21. North America Psoriasis Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. North America Psoriasis Treatment Drugs Market Share by Country (2020-2031)

Figure 23. United States Psoriasis Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Canada Psoriasis Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Psoriasis Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Europe Psoriasis Treatment Drugs Market Share by Country (2020-2031)

Figure 27. Germany Psoriasis Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. France Psoriasis Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. U.K. Psoriasis Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Italy Psoriasis Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Russia Psoriasis Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Nordic Countries Psoriasis Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Psoriasis Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Asia-Pacific Psoriasis Treatment Drugs Market Share by Region (2020-2031)

Figure 35. China Psoriasis Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Japan Psoriasis Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. South Korea Psoriasis Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Southeast Asia Psoriasis Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. India Psoriasis Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Australia Psoriasis Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Psoriasis Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Latin America Psoriasis Treatment Drugs Market Share by Country (2020-2031)

Figure 43. Mexico Psoriasis Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Brazil Psoriasis Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Psoriasis Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Middle East & Africa Psoriasis Treatment Drugs Market Share by Country (2020-2031)

Figure 47. Turkey Psoriasis Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Saudi Arabia Psoriasis Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. UAE Psoriasis Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. Amgen Revenue Growth Rate in Psoriasis Treatment Drugs Business (2020-2025)

Figure 51. Allergan Revenue Growth Rate in Psoriasis Treatment Drugs Business (2020-2025)

Figure 52. Dermira Revenue Growth Rate in Psoriasis Treatment Drugs Business (2020-2025)

Figure 53. Eli Lilly Revenue Growth Rate in Psoriasis Treatment Drugs Business (2020-2025)

Figure 54. Novartis Revenue Growth Rate in Psoriasis Treatment Drugs Business (2020-2025)

Figure 55. Merck Revenue Growth Rate in Psoriasis Treatment Drugs Business (2020-2025)

Figure 56. Johnson & Johnson Revenue Growth Rate in Psoriasis Treatment Drugs Business (2020-2025)

Figure 57. Pfizer Revenue Growth Rate in Psoriasis Treatment Drugs Business (2020-2025)

Figure 58. AstraZeneca Revenue Growth Rate in Psoriasis Treatment Drugs Business (2020-2025)

Figure 59. AbbVie Revenue Growth Rate in Psoriasis Treatment Drugs Business (2020-2025)

Figure 60. LEO Pharma Revenue Growth Rate in Psoriasis Treatment Drugs Business (2020-2025)

Figure 61. Biogen Revenue Growth Rate in Psoriasis Treatment Drugs Business (2020-2025)

Figure 62. Galectin Therapeutics Revenue Growth Rate in Psoriasis Treatment Drugs Business (2020-2025)

Figure 63. Cellceutix Revenue Growth Rate in Psoriasis Treatment Drugs Business (2020-2025)

Figure 64. Bayer Revenue Growth Rate in Psoriasis Treatment Drugs Business (2020-2025)

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

Figure 67. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Psoriatic Arthritis Treatment Drugs Market Research Report 2025

Global Psoriasis Biologics Drugs Market Research Report 2025

Psoriatic Arthritis Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Prescription Dermatology Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Still s Disease Treatment Market Research Report 2025

Global Treatment Planning Software Market Research Report 2025

Scar Removal Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Systemic Infection Treatment Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Prostate Cancer Diagnostics and Therapy Market Research Report 2024

Prostate Cancer Treatment Device Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Autoimmune Diseases Treatment Market Research Report 2024

Global Combination Therapy Drug Market Research Report 2025

Uveitis Treatment Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Hair Loss Growth Treatment Market Research Report 2025

Hair Loss Treatment for Man Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Acne Treatment Products Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Prescription Dermatological Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Scleroderma Treatment Market Research Report 2025

Global Alopecia Treatment Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions